What is the current stock price of Stella Pharma Corporation (4888.T)?

As of the latest market data, Stella Pharma Corporation (4888.T) is trading at $0.00. The stock has seen a loss of undefined% today.

Does Stella Pharma Corporation (4888.T) pay a dividend?

Based on current data, Stella Pharma Corporation does not have a confirmed active dividend policy.

What is the market cap of Stella Pharma Corporation?

The current market capitalization of Stella Pharma Corporation (4888.T) is approximately unavailable.

4888.T

Stella Pharma Corporation·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.00

Company Profile

Stella Pharma Corporation engages in the research, development, manufacturing, and distribution of pharmaceuticals. The company develops drugs for boron neutron capture therapy (BNCT). Its product includes SPM-011, a boron-containing drug for BNCT used for treating head and neck cancer, recurrent malignant glioma and meningioma, and malignant melanoma and angiosarcoma. The company was incorporated in 2007 and is headquartered in Osaka, Japan.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2021-04-22

Beta

0.47

Websitewww.stella-pharma.co.jp↗